<DOC>
	<DOCNO>NCT00984984</DOCNO>
	<brief_summary>The efficacy oral corticosteroid treatment relapse multiple sclerosis prove . French neurologist treat patient intravenous corticosteroid . The aim study check efficacy high dose oral methylprednisolone similar efficacy intravenous ( IV ) prednisolone . The main criterion efficacy symptom recovery within 28 day inclusion .</brief_summary>
	<brief_title>Efficacy Safety Methylprednisolone Per o Versus IV Treatment Multiple Sclerosis ( MS ) Relapses</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>age 18 55 informed write consent multiple sclerosis ( Mc Donald criterion , relapsingremitting EDSS relapse : 0 5 relapse : increase 1 point 1 functional system Kurtzke , SF score affect &gt; 1 function except sensory ( &gt; 2 ) ; duration symptom &gt; 24 h fever previous relapse , and/or corticosteroid treatment &lt; 1 month present relapse first symptoms present relapse appear &gt; 15 day inclusion mitoxantrone cyclophosphamid natalizumab treatment diabetes infection control liver kidney failure psychiatric symptom control pregnancy hypersensibility methylprednisolone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>